COWAN ELVIA (SVP, Finance & CAO) sold 9.4% of their position (3K shares) of VAXCYTE, INC. on the open market
Open‑market sale worth $180.0K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 4/8/2026ACC: 0001960048-26-000007
Officer· SVP, Finance & CAO
Since Feb 2026
-3K
Net shares
Net seller
$180.0K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
3K acquired · 6K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+3K
Price / share
$25.92
Trade value
$77.76K
% of position
10.4%
4/7/2026
28.98K→31.98K
Common Stock
Direct
Shares
−3K
Price / share
$60.00
Trade value
$180K
% of position
9.4%
4/7/2026
31.98K→28.98K
Total
Net shares
+0.00
Net value
-$102.24K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/7/2026 | M · Option Exercise | +3K | $25.92 | $77.76K | 10.4% | 28.98K | 31.98K |
| Common Stock Direct | 4/7/2026 | S · Sale | −3K | $60.00 | $180K | 9.4% | 31.98K | 28.98K |
| Total | +0.00 | -$102.24K | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
3K shares
Shares
−3K
Strike price
25.92
Held after
93.07K
Exercisable
—
4/7/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock3K shares | 4/7/2026 | M · Option Exercise | −3K | 25.92 | — | 93.07K |